Cleared Traditional

K992734 - BECTON DICKINSON SYRINGE

K992734 is an FDA 510(k) clearance for BECTON DICKINSON SYRINGE, manufactured by Bd Becton Dickinson Vacutainer Systems Preanalytic. The device is a Class 2 General Hospital device with product code MEG cleared through the Traditional 510(k) pathway after a 49-day FDA review.

K992734 · Bd Becton Dickinson Vacutainer Systems Preanalytic · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1999
Decision
49d
Days
Class 2
Risk

K992734 is an FDA 510(k) clearance for the BECTON DICKINSON SYRINGE. Classified as Syringe, Antistick (product code MEG), Class II - Special Controls.

Submitted by Bd Becton Dickinson Vacutainer Systems Preanalytic (Franklin Lakes, US). The FDA issued a Cleared decision on October 1, 1999 after a review of 49 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5860 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Bd Becton Dickinson Vacutainer Systems Preanalytic devices

FDA 510(k) Submission Details - K992734

510(k) Number K992734 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 13, 1999
Decision Date October 01, 1999
Days to Decision 49 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
80d faster than avg
Panel avg: 129d · This submission: 49d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MEG Device Classification - Class 2, Special Controls

Product Code MEG Syringe, Antistick
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5860
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - MEG Syringe, Antistick

All 117
Devices cleared under the same product code (MEG) and FDA review panel - the closest regulatory comparables to K992734.
UNIVEC AUTO-DISABLE HYPODERMIC SYRINGE
K993996 · Univec, Inc. · Jul 2000
SOLOGUARD LOCKING PLUS SYRINGE
K993609 · Safeguard Medical Products, Inc. · Mar 2000
SUPERGUARD SAFETY SYRINGE
K990831 · U.S. Safety Syringes Co., Inc. · Mar 2000
PERSONAL INFUSOR WITH DRUG DISPOSAL SEPTAL PORT
K990208 · Science Incorporated · Mar 1999
NMT SAFETY SYRINGE
K982431 · New Medical Technology , Ltd. · Nov 1998
SMARTLOCK SAFETY SYRINGE
K973888 · Medical Innovation , Ltd. · Jun 1998